Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Belen, Pilo de la Fuente"'
Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment
Autor:
Susana Sainz de la Maza, Lucienne Costa-Frossard, Victoria Galán Sánchez-Seco, Julia Sabin-Muñoz, Mayra Gómez-Moreno, Judit Díaz-Díaz, Paula Salgado Cámara, Belen Pilo de la Fuente, Sara Moreno-García, Celia Oreja-Guevara, Lucía Ayuso-Peralta, Yolanda Aladro-Benito
Publikováno v:
Multiple sclerosis and related disorders. 49
Background Potential increase of cancer incidence is one of the main safety concerns of the disease-modifying therapies employed in Multiple Sclerosis (MS). Objective Detailed description of patients who developed cancer among a prospective cohort of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c402a1d690d6c382575383722cef5c48
https://pubmed.ncbi.nlm.nih.gov/33524928
https://pubmed.ncbi.nlm.nih.gov/33524928
Autor:
Belen, Pilo de la Fuente, Julia, Sabín, Victoria, Galán, Israel, Thuissard, Susana, Sainz de la Maza, Lucienne, Costa-Frossard, Mayra, Gómez-Moreno, Judit, Díaz-Díaz, Celia, Oreja-Guevara, Alberto, Lozano-Ros, José M, García-Domínguez, Laura, Borrego, Lucía, Ayuso, Andy, Castro, Pedro, Sánchez, Virginia, Meca-Lallana, Carmen, Muñoz, Ignacio, Casanova, Carlos, López de Silanes, Hugo, Martín, Elena, Rodríguez-García, Cristina, Andreu-Vázquez, Rosario, Blasco, Juan A, García-Merino, Yolanda, Aladro, Ricardo, Ginestal
Publikováno v:
CNS drugs. 34(12)
Dimethyl fumarate (DMF) has demonstrated efficacy in phase III studies. However, real-world data are still limited.The objective of this study was to describe the profile of patients who receive DMF and to assess the effectiveness of DMF regarding re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c83e6ff1b2366b2c57edf74618b69ff0
https://pubmed.ncbi.nlm.nih.gov/33226562
https://pubmed.ncbi.nlm.nih.gov/33226562
Autor:
Alberto Lozano-Ros, Susana Sainz de la Maza, Lucía Ayuso, Judit Díaz-Díaz, Belen Pilo de la Fuente, Julia Sabin, Israel Thuissard, Laura Borrego, Andy Castro, Carmen Muñoz, Carlos López de Silanes, Pedro Sánchez, J.A. García-Merino, Ignacio Casanova, Cristina Andreu-Vázquez, Rosario Blasco, Mayra Gómez-Moreno, José M. García-Domínguez, Virginia Meca-Lallana, Victoria Galan, Yolanda Aladro, Lucienne Costa-Frossard, Hugo Martín, Elena Rodríguez-García, Celia Oreja-Guevara
Background: Dimethyl fumarate (DMF) has demonstrated efficacy in phase III studies. However, real-world data are still limited. Objective: The objective of this study was to describe the profile of patients who receive DMF and to assess the effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15099d0873117e1cc82c6be18e2276fe
https://hdl.handle.net/11268/9901
https://hdl.handle.net/11268/9901
Autor:
Maria Asuncion de la Morena Vicente, Hugo Martín García, Belen Pilo de la Fuente, Belen Anaya Caravaca, Maria Sagrario Manzano Palomo, Loreto Ballesteros Plaza, David Andres Perez Martinez
Publikováno v:
Alzheimer's & Dementia. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e408aae90835c4294d6d8032688970dc
https://doi.org/10.1016/j.jalz.2015.06.934
https://doi.org/10.1016/j.jalz.2015.06.934